Cite
Experience of treatment in critical Guillain‐Barre Syndrome case after COVID‐19 vaccination.
MLA
Zhu, Chunying, et al. “Experience of Treatment in Critical Guillain‐Barre Syndrome Case after COVID‐19 Vaccination.” International Journal of Developmental Neuroscience, vol. 84, no. 4, June 2024, pp. 342–48. EBSCOhost, https://doi.org/10.1002/jdn.10325.
APA
Zhu, C., Wang, H., Zhang, Y., Wang, W., Wang, J., & Li, W. (2024). Experience of treatment in critical Guillain‐Barre Syndrome case after COVID‐19 vaccination. International Journal of Developmental Neuroscience, 84(4), 342–348. https://doi.org/10.1002/jdn.10325
Chicago
Zhu, Chunying, Huan Wang, Yingfu Zhang, Wentao Wang, Jia Wang, and Wei Li. 2024. “Experience of Treatment in Critical Guillain‐Barre Syndrome Case after COVID‐19 Vaccination.” International Journal of Developmental Neuroscience 84 (4): 342–48. doi:10.1002/jdn.10325.